2m 2m 2m 2m 2m 2m 2m
KEROS THERAP (KROS)
NASDAQ
$11.05+$0.02 (+0.14%)
Price as of Aug 21, 2026 4:10 PM EDT- $218.7MMarket Cap
- -29.11%1-Year Change
- BiotechnologyIndustry
KEROS THERAP (KROS)
$11.05+$0.02 (+0.14%)
KROS | vs History | vs S&P 500 | |
|---|---|---|---|
General Statistics | |||
Latest Close | $11.03 | ||
Change | +$0.08 (+0.73%) | ||
Open | $10.96 | ||
High | $11.09 | ||
Low | $10.80 | ||
Previous Close | $10.95 | ||
Volume | 157,507 | ||
30-Day Average Volume | 208,370 | ||
1-Week Change | 9.21% | ||
1-Month Change | 4.35% | ||
1-Year Change | -29.11% | ||
3-Year Change | -69.03% | ||
5-Year Change | -65.43% | ||
Fundamentals | |||
Shares Outstanding | 19.8M | ||
Total Assets | $287.6M | ||
Market Cap | $218.7M | ||
Enterprise Value | -$38.9M | ||
Period: QTR TTM FY | |||
Revenue | $0.00 | ||
Net Income | -$28.7M | ||
Free Cash Flow | -$20.6M | ||
EBIT | -$28.7M | ||
EBITDA | -$28.3M | ||
Net Working Capital | $254.7M | ||
EPS | -$1.45 | ||
Enterprise Value/EBITDA | 1 | ||
Enterprise Value/Revenue | N/A | ||
P/B | 1 | ||
P/E | -8 | ||
PEG | 0 | ||
Price/Free Cash Flow | -11 | ||
Price/Operating Cash Flow | -11 | ||
Dividends & Splits | |||
Forward Annual Dividend Yield | N/A | ||
Trailing Annual Dividend Yield | N/A | ||
Ex-Dividend Date | N/A | ||
Last Split Factor | N/A | ||
Last Split Date | N/A | ||
Earnings & Revenue